OptoMonitor
Transducer, Pressure, Catheter Tip. 510(k) K192340, from Opsens, Inc. (Quebec, CA). Product code DXO, class 2.
As of Nov 20, 2026, K192340 is an FDA 510(k) held by Opsens, Inc., substantially equivalent on Dec 12, 2019 after 106 days, with no recalls tied to it in FDA's recall database.
- Review time: 106 days
- Recalls: 0
- Cited as a predicate by: 2 devices
To measure pressure in bod vessels including both coronary and peripheral vessels, during diagnostic angiography and/or any interventional procedures. Blood pressure measurements provide hemodynamic information, such as fractional flow reserve, for the diagnosis and treatment of blood vessels.
- Opto Wire and OptoMonitor SystemK142598 · Opsens, Inc. · Jun 12, 2015
- s5 Intravascular Ultrasound Imaging and Pressure Systems, s5i Intravascular Ultrasound Imaging and Pressure Systems,…K173860 · Volcano Corporation · Apr 11, 2018
- Primewire Prestige PlusK111395 · Volcano Corporation · Aug 1, 2011
- Volcano Ifr ModalityK133323 · Volcano Corporation · Mar 14, 2014
- Combomap Pressure and Flow SystemK041134 · Volcano Therapeutics, Inc. · Jun 2, 2004
- Ffr V2.5K170133 · Philips Volcano · May 26, 2017
- OptoMonitor 3K202943 · Opsens, Inc. · Nov 24, 2020
- OptoMonitor 3K193620 · Opsens, Inc. · Jun 18, 2020
- OptoMonitor 3K251367 · Opsens, Inc. · Jan 16, 2026
- OptoMonitor 3K241418 · Opsens, Inc. · Feb 12, 2025
- ACIST RXi System (016616); ACIST Navvus II Catheter (016675_K233904 · Acist Medical Systems, Inc. · Jul 17, 2024
- TruWave Disposable Pressure TransducerK222216 · Edwards Lifesciences, LLC · Dec 22, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 28, 2019
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.2870
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files